Lower-Limb Amputation: An increased risk of lower-limb amputations associated with INVOKANA use versus placebo was observed in CANVAS (. vs . events per patient-years) and CANVAS-R (. vs . events per patient-years), two randomized, placebo-controlled trials evaluating patients with type diabetes who had either established cardiovascular disease or were at risk for cardiovascul...
2.48 Rating by Usitestat
invokanahcp.com was registered 1 decade 1 year ago. It has a alexa rank of #3,877,135 in the world. It is a domain having .com extension. It is estimated worth of $ 240.00 and have a daily income of around $ 1.00. As no active threats were reported recently, invokanahcp.com is SAFE to browse.
The Official INVOKANA® Health Care Professional website. See full Prescribing & Safety Information & Boxed Warning.
Website Inpage Analysis
H1 Headings:
1
H2 Headings:
2
H3 Headings:
2
H4 Headings:
Not Applicable
H5 Headings:
Not Applicable
H6 Headings:
Not Applicable
Total IFRAMEs:
1
Total Images:
8
Google Adsense:
Not Applicable
Google Analytics:
Not Applicable
Two Phrase Analysis
Words
Occurrences
Density
Possible Spam
in patients
22
1.023 %
No
patients with
17
0.79 %
No
risk of
15
0.697 %
No
glycemic control
10
0.465 %
No
2 diabetes
9
0.418 %
No
the risk
8
0.372 %
No
with INVOKANA®
8
0.372 %
No
is not
8
0.372 %
No
with type
7
0.325 %
No
of the
7
0.325 %
No
INVOKANA® is
7
0.325 %
No
type 2
7
0.325 %
No
and symptoms
7
0.325 %
No
signs and
7
0.325 %
No
in the
6
0.279 %
No
and diabetic
6
0.279 %
No
100 mg
6
0.279 %
No
Pharmaceuticals Inc
6
0.279 %
No
diabetes mellitus
6
0.279 %
No
SGLT2 inhibitors
6
0.279 %
No
Four Phrase Analysis
Words
Occurrences
Density
Possible Spam
is not recommended in
5
0.232 %
No
with type 2 diabetes
5
0.232 %
No
reduce the risk of
5
0.232 %
No
to reduce the risk
4
0.186 %
No
for signs and symptoms
4
0.186 %
No
events per 1000 patientyears
4
0.186 %
No
type 2 diabetes mellitus
4
0.186 %
No
signs and symptoms of
3
0.139 %
No
INVOKANA® is not recommended
3
0.139 %
No
not recommended in patients
3
0.139 %
No
prior amputation peripheral vascular
3
0.139 %
No
and diabetic foot ulcers
3
0.139 %
No
once daily in patients
3
0.139 %
No
daily in patients currently
3
0.139 %
No
amputation peripheral vascular disease
3
0.139 %
No
in patients with type
3
0.139 %
No
of prior amputation peripheral
3
0.139 %
No
in adults with type
3
0.139 %
No
SGLT2 inhibitors including INVOKANA®
3
0.139 %
No
receiving SGLT2 inhibitors including
3
0.139 %
No
Mobile Friendly Check
Mobile Friendly : Yes Score : 99
Mobile viewport not set: 0 Text too small to read: 0 Uses incompatible plugins: 0 Content wider than screen: 0 Links too close together: 0.33240997229917 CMS: DRUPAL Locale: en_US Roboted Resources: 1 Transient Fetch Failure Resources: 0
J. R. R. Tolkien Collecting guides, forums, articles, and news. A database of Tolkien related collectibles, rare items, ephemera. A community of like-minded collectors who...